The immune response in autism: A new frontier for autism research

Journal of Leukocyte Biology

Volumn 80, Issue 1, 2006, Pages 1-15

  Ashwood, Paul ^a,c   Wills, Sharifia ^b   Van De Water, Judy ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism spectrum disorder (ASD); Cytokines; Immunity; Inflammation; Neurodevelopment; Neurokine

Indexed keywords

CD45 ANTIGEN; CLOZAPINE; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 12; NALTREXONE; OPIATE PEPTIDE; PARACETAMOL; RISPERIDONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ALLELE; AUTISM; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BRAIN DYSFUNCTION; COMPULSION; DEVELOPMENTAL DISORDER; EMBRYO DEVELOPMENT; ENVIRONMENTAL FACTOR; HELPER CELL; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; INFANTILE AUTISM; LYMPHOCYTE COUNT; MITOGENESIS; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NONVERBAL COMMUNICATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REVIEW; SOCIAL INTERACTION; STEREOTYPY; TH1 CELL; TH2 CELL; VERBAL COMMUNICATION;

ANIMALS; AUTISTIC DISORDER; AUTOIMMUNITY; COMPLEMENT C4; HLA-DR ANTIGENS; HUMANS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 33751581761     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1205707     Document Type: Review

References (199)

1. Association, A. P. (1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Washington, DC, American Psychiatric Association.
2. Fombonne, E. (2003) The prevalence of autism. JAMA 289, 87-89.
3. Wiznitzer, M. (2004) Autism and tuberous sclerosis. J. Child Neurol. 19, 675-679.
4. Rutter, M. (2000) Genetic studies of autism: from the 1970s into the millennium. J. Abnorm. Child Psychol. 28, 3-14.
5. Cohen, D., Pichard, N., Tordjman, S., Baumann, C., Burglen, L., Excoffier, E., Lazar, G., Mazet, P., Pinquier, C., Verloes, A., Heron, D. (2005) Specific genetic disorders and autism: clinical contribution towards their identification. J. Autism Dev. Disord. 35, 103-116.
6. Baird, G., Cass, H., Slonims, V. (2003) Diagnosis of autism. BMJ 327, 488-493.
7. Cook, E. (1998) Genetics of autism. Ment. Retard. Dev. Disabil. Res. Rev. 4, 113-120.
8. Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., Rutter, M. (1995) Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25, 63-77.
9. Hallmayer, J., Glasson, E. J., Bower, C., Petterson, B., Croen, L., Grether, J., Risch, N. (2002) On the twin risk in autism. Am. J. Hum. Genet. 71, 941-946.
10. Cook Jr., E. H. (2001) Genetics of autism. Child Adolesc. Psychiatr. Clin. N. Am. 10, 333-350.
11. Risch, N., Spiker, D., Lotspeich, L., Nouri, N., Hinds, D., Hallmayer, J., Kalaydjieva, L., McCague, P., Dimiceli, S., Pitts, T., et al. (1999) A genomic screen of autism: evidence for a multilocus etiology. Am. J. Hum. Genet. 65, 493-507.
12. Polleux, F., Lauder, J. M. (2004) Toward a developmental neurobiology of autism. Ment. Retard. Dev. Disabil. Res. Rev. 10, 303-317.
13. Burger, R. A., Warren, R. P. (1998) Possible immunogenetic basis for autism. Ment. Retard. Dev. Disabil. Res. Rev. 4, 137-141.
14. Rice, D., Barone Jr., S. (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108 (Suppl. 3), 511-533.
15. Akshoomoff, N., Pierce, K., Courchesne, E. (2002) The neurobiological basis of autism from a developmental perspective. Dev. Psychopathol. 14, 613-634.
16. Acosta, M. T., Pearl, P. L. (2004) Imaging data in autism: from structure to malfunction. Semin. Pediatr. Neurol. 11, 205-213.
17. Courchesne, E., Karns, C. M., Davis, H. R., Ziccardi, R., Carper, R. A., Tigue, Z. D., Chisum, H. J., Moses, P., Pierce, K., Lord, C., et al. (2001) Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 57, 245-254.
18. Palmen, S. J., van Engeland, H., Hof, P. R., Schmitz, C. (2004) Neuropathological findings in autism. Brain 127, 2572-2583.
19. Volkmar, F., Cook Jr., E. H., Pomeroy, J., Realmuto, G., Tanguay, P. (1999) Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J. Am. Acad. Child Adolesc. Psychiatry 38, 32S-54S.
20. Tuchman, R. F., Rapin, I., Shinnar, S. (1991) Autistic and dysphasic children. I: clinical characteristics. Pediatrics 88, 1211-1218.
21. Villalobos, R., T. R., Jayakar, P., Yaylali, I. (1996) Prolonged EEG monitoring findings in children with pervasive developmental disorder and regression. Ann. Neurol. 40, 300.
22. Jarskog, L. F., Xiao, H., Wilkie, M. B., Lauder, J. M., Gilmore, J. H. (1997) Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int. J. Dev. Neurosci. 15, 711-716.
23. Steinman, L., Conlon, P., Maki, R., Foster, A. (2003) The intricate interplay among body weight, stress, and the immune response to friend or foe. J. Clin. Invest. 111, 183-185.
24. Tracey, K. J., Wei, H., Manogue, K. R., Fong, Y., Hesse, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., Cerami, A., et al. (1988) Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167, 1211-1227.
25. Dunzendorfer, S., Kaser, A., Meierhofer, C., Tilg, H., Wiedermann, C. J. (2001) Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J. Immunol. 166, 2167-2172.
26. Stubbs, E. G., Crawford, M. L. (1977) Depressed lymphocyte responsiveness in autistic children. J. Autism Child. Schizophr. 7, 49-55.
27. Warren, R. P., Margaretten, N. C., Pace, N. C., Foster, A. (1986) Immune abnormalities in patients with autism. J. Autism Dev. Disord. 16, 189-197.
28. Plioplys, A. V., Greaves, A., Kazemi, K., Silverman, E. (1994) Lymphocyte function in autism and Rett syndrome. Neuropsychobiology 29, 12-16.
29. Engstrom, A. H., Ohlson, S., Stubbs, E. G., Maciulus, A., Caldwell, V., Odell, J. D., Torres, A. R. (2003) Decreased expression of CD95 (FAS/ APO-1) on CD4+ T-lymphocytes from participants with autism. J. Dev. Phys. Disabil. 15, 155-163.
30. Ashwood, P., Anthony, A., Pellicer, A. A., Torrente, F., Walker-Smith, J. A., Wakefield, A. J. (2003) Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J. Clin. Immunol. 23, 504-517.
31. Ferrante, P., Saresella, M., Guerini, F. R., Marzorati, M., Musetti, M. C., Cazzullo, A. G. (2003) Significant association of HLA A2-DR11 with CD4 naive decrease in autistic children. Biomed. Pharmacother. 57, 372-374.
32. Yonk, L. J., Warren, R. P., Burger, R. A., Cole, P., Odell, J. D., Warren, W. L., White, E., Singh, V. K. (1990) CD4+ helper T cell depression in autism. Immunol. Lett. 25, 341-345.
33. Warren, R. P., Yonk, L. J., Burger, R. A., Cole, P., Odell, J. D., Warren, W. L., White, E., Singh, V. K. (1990) Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol. Invest. 19, 245-251.
34. Denney, D. R., Frei, B. W., Gaffney, G. R. (1996) Lymphocyte subsets and interleukin-2 receptors in autistic children. J. Autism Dev. Disord. 26, 87-97.
35. Sweeten, T. L., Posey, D. J., Shanker, S., McDougle, C. J. (2004) High nitric oxide production in autistic disorder: possible role for interferron-γ. Biol. Psychiatry 55, 434-437.
36. Sweeten, T. L., Posey, D. J., McDougle, C. J. (2003) High blood monocyte counts and neopterin levels in children with autistic disorder. Am. J. Psychiatry 160, 1691-1693.
37. Messahel, S., Pheasant, A. E., Pall, H., Ahmed-Choudhury, J., Sungum-Paliwal, R. S., Vostanis, P. (1998) Urinary levels of neopterin and biopterin in autism. Neurosci. Lett. 241, 17-20.
38. Fiumara, A., Sciotto, A., Barone, R., D'Asero, G., Munda, S., Parano, E., Pavone, L. (1999) Peripheral lymphocyte subsets and other immune aspects in Rett syndrome. Pediatr. Neurol. 21, 619-621.
39. Warren, R. P., Foster, A., Margaretten, N. C. (1987) Reduced natural killer cell activity in autism. J. Am. Acad. Child Adolesc. Psychiatry 26, 333-335.
40. Singh, V. K. (1996) Plasma increase of interleukin-12 and interferon-γ. Pathological significance in autism. J. Neuroimmunol. 66, 143-145.
41. Gupta, S., Aggarwal, S., Rashanravan, B., Lee, T. (1998) Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J. Neuroimmunol. 85, 106-109.
42. Zimmerman, A. W., Jyonouchi, H., Comi, A. M., Connors, S. L., Milstien, S., Varsou, A., Heyes, M. P. (2005) Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr. Neurol. 33, 195-201.
43. Jyonouchi, H., Sun, S., Le, H. (2001) Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 120, 170-179.
44. + lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 173, 126-134.
45. Ashwood, P., Anthony, A., Torrente, F., Wakefield, A. J. (2004) Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J. Clin. Immunol. 24, 664-673.
46. Jyonouchi, H., Geng, L., Ruby, A., Reddy, C., Zimmerman-Bier, B. (2005) Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J. Pediatr. 146, 605-610.
47. Croonenberghs, J., Wauters, A., Devreese, K., Verkerk, R., Scharpe, S., Bosmans, E., Egyed, B., Deboutte, D., Maes, M. (2002) Increased serum albumin, γ globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol. Med. 32, 1457-1463.
48. Trajkovski, V., Ajdinski, L., Spiroski, M. (2004) Plasma concentration of immunoglobulin classes and subclasses in children with autism in the Republic of Macedonia: retrospective study. Croat. Med. J. 45, 746-749.
49. Singh, V. K., Warren, R. P., Odell, J. D., Warren, W. L., Cole, P. (1993) Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 7, 97-103.
50. Singh, V. K., Warren, R., Averett, R., Ghaziuddin, M. (1997) Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 17, 88-90.
51. Todd, R. D., Hickok, J. M., Anderson, G. M., Cohen, D. J. (1988) Antibrain antibodies in infantile autism. Biol. Psychiatry 23, 644-647.
52. Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., Deuel, R. K. (1999) Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J. Pediatr. 134, 607-613.
53. Silva, S. C., Correia, C., Fesel, C., Barreto, M., Coutinho, A. M., Marques, C., Miguel, T. S., Ataide, A., Bento, C., Borges, L., Oliveira, G., Vicente, A. M. (2004) Autoantibody repertoires to brain tissue in autism nuclear families. J. Neuroimmunol. 152, 176-182.
54. Odell, D., Maciulis, A., Cutler, A., Warren, L., McMahon, W. M., Coon, H., Stubbs, G., Henley, K., Torres, A. (2005) Confirmation of the association of the C4B null allelle in autism. Hum. Immunol. 66, 140-145.
55. Torres, A. R., Maciulis, A., Odell, D. (2001) The association of MHC genes with autism. Front. Biosci. 6, D936-D943.
56. Korvatska, E., Van de Water, J., Anders, T. F., Gershwin, M. E. (2002) Genetic and immunologic considerations in autism. Neurobiol. Dis. 9, 107-125.
57. Krause, I., He, X. S., Gershwin, M. E., Shoenfeld, Y. (2002) Brief report: immune factors in autism: a critical review. J. Autism Dev. Disord. 32, 337-345.
58. Yamashita, Y., Fujimoto, C., Nakajima, E., Isagai, T., Matsuishi, T. (2003) Possible association between congenital cytomegalovirus infection and autistic disorder. J. Autism Dev. Disord. 33, 455-459.
59. Patterson, P. H. (2002) Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr. Opin. Neurobiol. 12, 115-118.
60. Hornig, M., Solbrig, M., Horscroft, N., Weissenbock, H., Lipkin, W. I. (2001) Borna disease virus infection of adult and neonatal rats: models for neuropsychiatric disease. Curr. Top. Microbiol. Immunol. 253, 157-177.
61. Plata-Salaman, C. R., Ilyin, S. E., Gayle, D., Romanovitch, A., Carbone, K. M. (1999) Persistent Borna disease virus infection of neonatal rats causes brain regional changes of mRNAs for cytokines, cytokine receptor components and neuropeptides. Brain Res. Bull. 49, 441-451.
62. Sauder, C., de la Torre, J. C. (1999) Cytokine expression in the rat central nervous system following perinatal Borna disease virus infection. J. Neuroimmunol. 96, 29-45.
63. Shi, L., Fatemi, S. H., Sidwell, R. W., Patterson, P. H. (2003) Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23, 297-302.
64. Stubbs, G. (1995) Interferonemia and autism. J. Autism Dev. Disord. 25, 71-73.
65. Gadient, R. A., Patterson, P. H. (1999) Leukemia inhibitory factor, interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells 17, 127-137.
66. Mehler, M. F., Kessler, J. A. (1998) Cytokines in brain development and function. Adv. Protein Chem. 52, 223-251.
67. Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., Pardo, C. A. (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57, 67-81.
68. Wilson, C. J., Finch, C. E., Cohen, H. J. (2002) Cytokines and cognition - the case for a head-to-toe inflammatory paradigm. J. Am. Geriatr. Soc. 50, 2041-2056.
69. Ransohoff, R. M., Kivisakk, P., Kidd, G. (2003) Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3, 569-581.
70. Dantzer, R., Bluthe, R. M., Laye, S., Bret-Dibat, J. L., Parnet, P., Kelley, K. W. (1998) Cytokines and sickness behavior. Ann. N. Y. Acad. Sci. 840, 586-590.
71. Mignini, F., Streccioni, V., Amenta, F. (2003) Autonomic innervation of immune organs and neuroimmune modulation. Auton. Autacoid Pharmacol. 23, 1-25.
72. Larson, S. J. (2002) Behavioral and motivational effects of immunesystem activation. J. Gen. Psychol. 129, 401-414.
73. Licinio, J., Kling, M. A., Hauser, P. (1998) Cytokines and brain function: relevance to interferon-α-induced mood and cognitive changes. Semin. Oncol. 25, 30-38.
74. Zhao, B., Schwartz, J. P. (1998) Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J. Neurosci. Res. 52, 7-16.
75. Kipnis, J., Cohen, H., Cardon, M., Ziv, Y., Schwartz, M. (2004) T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc. Natl. Acad. Sci. USA 101, 8180-8185.
76. Lam, K. S., Aman, M. G., Arnold, L. E. (2006) Neurochemical correlates of autistic disorder: a review of the literature. Res. Dev. Disabil. 27, 254-289.
77. Fatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., Realmuto, G. R. (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52, 805-810.
78. Bittigau, P., Ikonomidou, C. (1997) Glutamate in neurologic diseases. J. Child Neurol. 12, 471-485.
79. Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., Chugani, H. T. (1999) Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 45, 287-295.
80. Simmons, D. A., Broderick, P. A. (2005) Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 793-807.
81. Wirleitner, B., Neurauter, G., Schrocksnadel, K., Frick, B., Fuchs, D. (2003) Interferon-γ-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr. Med. Chem. 10, 1581-1591.
82. Anderson, G. M., Horne, W. C., Chatterjee, D., Cohen, D. J. (1990) The hyperserotonemia of autism. Ann. N. Y. Acad. Sci. 600, 331-340.
83. McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., Price, L. H. (1996) A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch. Gen. Psychiatry 53, 1001-1008.
84. Cook, E. H., Leventhal, B. L. (1996) The serotonin system in autism. Curr. Opin. Pediatr. 8, 348-354.
85. Coutinho, A. M., Oliveira, G., Morgadinho, T., Fesel, C., Macedo, T. R., Bento, C., Marques, C., Ataide, A., Miguel, T., Borges, L., Vicente, A. M. (2004) Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol. Psychiatry 9, 264-271.
86. Conroy, J., Meally, E., Kearney, G., Fitzgerald, M., Gill, M., Gallagher, L. (2004) Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol. Psychiatry 9, 587-593.
87. Biber, K., Zuurman, M. W., Dijkstra, I. M., Boddeke, H. W. G. M. (2002) Chemokines in the brain: neuroimmunology and beyond. Curr. Opin. Pharmacol. 2, 63-68.
88. Levi-Montalcini, R., Skaper, S. D., Dal Toso, R., Petrelli, L., Leon, A. (1996) Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci. 19, 514-520.
89. Nelson, K. B., Grether, J. K., Croen, L. A., Dambrosia, J. M., Dickens, B. F., Jelliffe, L. L., Hansen, R. L., Phillips, T. M. (2001) Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 49, 597-606.
90. Vega, J. A., Garcia-Suarez, O., Hannestad, J., Perez-Perez, M., Gennana, A. (2003) Neurotrophins and the immune system. J. Anat. 203, 1-19.
91. Nockher, W. A., Renz, H. (2003) Neurotrophins in inflammatory lung disease; modulators of cell differentiation and neuroimmune interactions. Cytokine Growth Factor Rev. 14, 559-578.
92. Young, L. J., Pitkow, L. J., Ferguson, J. N. (2002) Neuropeptides and social behavior: animal models relevant to autism. Mol. Psychiatry 7 (Suppl. 2), S38-S39.
93. Young, L. J., Wang, Z., Insel, T. R. (1998) Neuroendocrine bases of monogamy. Trends Neurosci. 21, 71-75.
94. Williams, J. R., Insel, T. R., Harbaugh, C. R., Carter, C. S. (1994) Oxytocin administered centrally facilitates formation of a partner preference in female prairie voles (Microtus ochrogaster). J. Neuroendocrinol. 6, 247-250.
95. Young, L. J., Lim, M. M., Gingrich, B., Insel, T. R. (2001) Cellular mechanisms of social attachment. Horm. Behav. 40, 133-138.
96. Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., Winslow, J. T. (2000) Social amnesia in mice lacking the oxytocin gene. Nat. Genet. 25, 284-288.
97. Modahl, C., Green, L., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., Levin, H. (1998) Plasma oxytocin levels in autistic children. Biol. Psychiatry 43, 270-277.
98. Green, L., Fein, D., Modahl, C., Feinstein, C., Waterhouse, L., Morris, M. (2001) Oxytocin and autistic disorder: alterations in peptide forms. Biol. Psychiatry 50, 609-613.
99. Delneste, Y., Herbault, N., Galea, B., Magistrelli, G., Bazin, I., Bonnefoy, J. Y., Jeannin, P. (1999) Vasoactive intestinal peptide synergizes with TNF-α in inducing human dendritic cell maturation. J. Immunol. 163, 3071-3075.
100. Pashenkov, M., Teleshova, N., Link, H. (2003) Inflammation in the central nervous system: the role for dendritic cells. Brain Pathol. 13, 23-33.
101. Money, J., Bobrow, N. A., Clarke, F. C. (1971) Autism and autoimmune disease: a family study. J. Autism Child. Schizophr. 1, 146-160.
102. Comi, A. M., Zimmerman, A. W., Frye, V. H., Law, P. A., Peeden, J. N. (1999) Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 14, 388-394.
103. Sweeten, T. L., Bowyer, S. L., Posey, D. J., Halberstadt, G. M., McDougle, C. J. (2003) Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 112, e420.
104. Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., Van de Water, J. (2005) Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch. Pediatr. Adolesc. Med. 159, 151-157.
105. Dalton, P., Deacon, R., Blamire, A., Pike, M., McKinlay, I., Stein, J., Styles, P., Vincent, A. (2003) Maternal antibodies associated with autism and language disorder. Ann. Neurol. 53, 533-537.
106. Todd, R. D., Ciaranello, R. D. (1985) Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc. Natl. Acad. Sci. USA 82, 612-616.
107. Rumsey, J. M., Ernst, M. (2000) Functional neuroimaging of autistic disorders. Ment. Retard. Dev. Disabil. Res. Rev. 6, 171-179.
108. Ahlsen, G., Rosengren, L., Belfrage, M., Palm, A., Haglid, K., Hamberger, A., Gillberg, C. (1993) Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol. Psychiatry 33, 734-743.
109. Singh, V. K., Rivas, W. H. (2004) Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci. Lett. 355, 53-56.
110. Horvath, K., Papadimitriou, J. C., Rabsztyn, A., Drachenberg, C., Tildon, J. T. (1999) Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 135, 559-563.
111. Afzal, N., Murch, S., Thirrupathy, K., Berger, L., Fagbemi, A., Heuschkel, R. (2003) Constipation with acquired megarectum in children with autism. Pediatrics 112, 939-942.
112. Fombonne, E., Simmons, H., Ford, T., Meltzer, H., Goodman, R. (2001) Prevalence of pervasive developmental disorders in the British nationwide survey of child mental health. J. Am. Acad. Child Adolesc. Psychiatry 40, 820-827.
113. Finegold, S. M., Molitoris, D., Song, Y., Liu, C., Vaisanen, M. L., Bolte, E., McTeague, M., Sandler, R., Wexler, H., Marlowe, E. M., et al. (2002) Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 35, S6-S16.
114. Knivsberg, A. M., Reichelt, K. L., Hoien, T., Nodland, M. (2002) A randomised, controlled study of dietary intervention in autistic syndromes. Nutr. Neurosci. 5, 251-261.
115. D'Eufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E., Giardini, O. (1996) Abnormal intestinal permeability in children with autism. Acta Paediatr. 85, 1076-1079.
116. Alberti, A., Pirrone, P., Elia, M., Waring, R. H., Romano, C. (1999) Sulphation deficit in "low-functioning" autistic children: a pilot study. Biol. Psychiatry 46, 420-424.
117. Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., Casson, D. M., Malik, M., Berelowitz, M., Dhillon, A. P., Thomson, M. A., Harvey, P., Valentine, A., Davies, S. E., Walker-Smith, J. A. (1998) Ileal-lymphoidnodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351, 637-641.
118. Wakefield, A. J., Ashwood, P., Limb, K., Anthony, A. (2005) The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur. J. Gastroenterol. Hepatol. 17, 827-836.
119. Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., Montgomery, S. M., Davies, S., O'Leary, J. J., Berelowitz, M., Walker-Smith, J. A. (2000) Enterocolitis in children with developmental disorders. Am. J. Gastroenterol. 95, 2285-2295.
120. Furlano, R. I., Anthony, A., Day, R., Brown, A., McGarvey, L., Thomson, M. A., Davies, S. E., Berelowitz, M., Forbes, A., Wakefield, A. J., Walker-Smith, J. A., Murch, S. H. (2001) Colonic CD8 and γ δ T-cell infiltration with epithelial damage in children with autism. J. Pediatr. 138, 366-372.
121. Torrente, F., Ashwood, P., Day, R., Machado, N., Furlano, R. I., Anthony, A., Davies, S. E., Wakefield, A. J., Thomson, M. A., Walker-Smith, J. A., Murch, S. H. (2002) Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol. Psychiatry 7, 375-382.
122. Ashwood, P., Anthony, A., Pellicier, A. A., Torrente, F., Walker-Smith, J. A., Wakefield, A. (2003) Intestinal lymphoctye populations in children with regressive autism: evidence for extensive mucosal immunopathology. J. Clin. Immunol. 23, 504-517.
123. Wakefield, A. J. (2002) Enterocolitis, autism and measles virus. Mol. Psychiatry 7 (Suppl. 2), S44-S46.
124. Jass, J. R. (2005) The intestinal lesion of autistic spectrum disorder. Eur. J. Gastroenterol. Hepatol. 17, 821-822.
125. Kokkonen, J., Ruuska, T., Karttunen, T. J., Maki, M. (2002) Lymphonodular hyperplasia of the terminal ileum associated with colitis shows an increase γδ+ T-cell density in children. Am. J. Gastroenterol. 97, 667-672.
126. Welch, M. G., Welch-Horan, T. B., Anwar, M., Anwar, N., Ludwig, R. J., Ruggiero, D. A. (2005) Brain effects of chronic IBD in areas abnormal in autism and treatment by single neuropeptides secretin and oxytocin. J. Mol. Neurosci. 25, 259-274.
127. Bushara, K. O. (2005) Neurologic presentation of celiac disease. Gastroenterology 128, S92-S97.
128. Lucarelli, S., Frediani, T., Zingoni, A. M., Ferruzzi, F., Giardini, O., Quintieri, F., Barbato, M., D'Eufemia, P., Cardi, E. (1995) Food allergy and infantile autism. Panminerva Med. 37, 137-141.
129. Vojdani, A., Campbell, A. W., Anyanwu, E., Kashanian, A., Bock, K., Vojdani, E. (2002) Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J. Neuroimmunol. 129, 168-177.
130. Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Vaisanen, M. L., Nelson, M. N., Wexler, H. M. (2000) Short-term benefit from oral vancomycin treatment of regressive-onset autism. J. Child Neurol. 15, 429-435.
131. Knivsberg, A. M., Reichelt, K. L., Hoien, T., Nodland, M. (2002) A randomized, controlled study of dietary intervention in autistic syndromes. Nutr. Neurosci. 5, 251-261.
132. Pedotti, R., De Voss, J. J., Steinman, L., Galli, S. J. (2003) Involvement of both "allergic" and "autoimmune" mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24, 479-484.
133. Zagon, I. S., McLaughlin, P. J. (1991) Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res. 542, 318-323.
134. Weigent, D. A., Blalock, J. E. (1997) Neuroendocrine-immune interactions. In Immunology of the Nervous System (Keane, R. W., Hickey, W. F., eds.) pp. 548-575, Oxford University Press, New York.
135. Peterson, P. K., Molitor, T. W., Chao, C. C. (1998) The opioid-cytokine connection. J. Neuroimmunol. 83, 63-69.
136. Wakefield, A. J., Puleston, J. M., Montgomery, S. M., Anthony, A., O'Leary, J. J., Murch, S. H. (2002) Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment. Pharmacol. Ther. 16, 663-674.
137. Whitely, P., Rogers, J., Savery, D., Shattock, P. (1999) A gluten-free diet as an intervention for autism and associated spectrum disorders: preliminary findings. Autism 3, 45-65.
138. Symons, F. J., Thompson, A., Rodriguez, M. C. (2004) Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis. Ment. Retard. Dev. Disabil. Res. Rev. 10, 193-200.
139. Fatemi, S. H., Earle, J., Kanodia, R., Kist, D., Emamian, E. S., Patterson, P. H., Shi, L., Sidwell, R. (2002) Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell. Mol. Neurobiol. 22, 25-33.
140. Luppi, P. (2003) How immune mechanisms are affected by pregnancy. Vaccine 21, 3352-3357.
141. Libbey, J. E., Sweeten, T. L., McMahon, W. M., Fujinami, R. S. (2005) Autistic disorder and viral infections. J. Neurovirol. 11, 1-10.
142. Lopez-Pison, J., Rubio-Rubio, R., Urena-Hornos, T., Omenaca-Teres, M., Sans, A., Cabrerizo de Diago, R., Pena-Segura, J. L. (2005) Retrospective diagnosis of congenital infection by cytomegalovirus in the case of one infant. Rev. Neurol. 40, 733-736.
143. Pletnikov, M. V., Moran, T. H., Carbone, K. M. (2002) Borna disease virus infection of the neonatal rat: developmental brain injury model of autism spectrum disorders. Front. Biosci. 7, d593-d607.
144. Hans, A., Bajramovic, J. J., Syan, S., Perret, E., Dunia, I., Brahic, M., Gonzalez-Dunia, D. (2004) Persistent, noncytolytic infection of neurons by Borna disease virus interferes with ERK 1/2 signaling and abrogates BDNF-induced synaptogenesis. FASEB J. 18, 863-865.
145. Pletnikov, M. V., Jones, M. L., Rubin, S. A., Moran, T. H., Carbone, K. M. (2001) Rat model of autism spectrum disorders. Genetic background effects on Borna disease virus-induced developmental brain damage. Ann. N. Y. Acad. Sci. 939, 318-319.
146. Chess, S., Fernandez, P., Korn, S. (1978) Behavioral consequences of congenital rubella. J. Pediatr. 93, 699-703.
147. Swisher, C. N., Swisher, L. (1975) Letter: congenital rubella and autistic behavior. N. Engl. J. Med. 293, 198.
148. Hornig, M., Chian, D., Lipkin, W. I. (2004) Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol. Psychiatry 9, 833-845.
149. Geier, D. A., Geier, M. R. (2004) A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med. Sci. Monit. 10, PI33-PI39.
150. Ingram, J. L., Peckham, S. M., Tisdale, B., Rodier, P. M. (2000) Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 22, 319-324.
151. Bachevalier, J. (1996) Brief report: medial temporal lobe and autism: a putative animal model in primates. J. Autism Dev. Disord. 26, 217-220.
152. Wolterink, G., Daenen, L. E., Dubbeldam, S., Gerrits, M. A., van Rijn, R., Kruse, C. G., Van Der Heijden, J. A., Van Ree, J. M. (2001) Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders. Eur. Neuropsychopharmacol. 11, 51-59.
153. Birkett, S. D., Pickering, B. T. (1988) The vasopressin precursor in the Brattleboro (di/di) rat. Int. J. Pept. Protein Res. 32, 565-572.
154. Long, J. M., LaPorte, P., Paylor, R., Wynshaw-Boris, A. (2004) Expanded characterization of the social interaction abnormalities in mice lacking Dvl1. Genes Brain Behav. 3, 51-62.
155. Winslow, J. T., Insel, T. R. (2002) The social deficits of the oxytocin knockout mouse. Neuropeptides 36, 221-229.
156. Caston, J., Yon, E., Mellier, D., Godfrey, H. P., Delhaye-bouchaud, N., Mariani, J. (1998) An animal model of autism: behavioural studies in the GS guinea-pig. Eur. J. Neurosci. 10, 2677-2684.
157. Lang, B., Dale, R. C., Vincent, A. (2003) New autoantibody mediated disorders of the central nervous system. Curr. Opin. Neurol. 16, 351-357.
158. Gaughran, F. (2002) Immunity and schizophrenia: autoimmunity, cytokines, and immune responses. Int. Rev. Neurobiol. 52, 275-302.
159. Jones, A. L., Mowry, B. J., Pender, M. P., Greer, J. M. (2005) Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol. Cell Biol. 83, 9-17.
160. Radewicz, K., Garey, L. J., Gentleman, S. M., Reynolds, R. (2000) Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J. Neuropathol. Exp. Neurol. 59, 137-150.
161. Bayer, T. A., Buslei, R., Havas, L., Falkai, P. (1999) Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci. Lett. 271, 126-128.
162. Pandey, R. S., Gupta, A. K., Chaturvedi, U. C. (1981) Autoimmune model of schizophrenia with special reference to antibrain antibodies. Biol. Psychiatry 16, 1123-1136.
163. Kim, J. J., Lee, S. J., Toh, K. Y., Lee, C. U., Lee, C., Paik, I. H. (2001) Identification of antibodies to heat shock proteins 90 kDa and 70 kDa in patients with schizophrenia. Schizophr. Res. 52, 127-135.
164. Jun, T. Y., Pae, C. U., Chae, J. H., Bahk, W. M., Kim, K. S., Han, H. (2002) Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population. Psychiatry Res. 110, 19-25.
165. Zhang, X. Y., Zhou, D. F., Zhang, P. Y., Wu, G. Y., Cao, L. Y., Shen, Y. C. (2002) Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr. Res. 57, 247-258.
166. Zhang, X. Y., Zhou, D. F., Cao, L. Y., Zhang, P. Y., Wu, G. Y. (2002) Decreased production of interleukin-2 (IL-2), IL-2 secreting cells and CD4+ cells in medication-free patients with schizophrenia. J. Psychiatr. Res. 36, 331-336.
167. Muller, N., Ackenheil, M. (1995) Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology. Schizophr. Res. 14, 223-228.
168. Albrecht, P., Torrey, E. F., Boone, E., Hicks, J. T., Daniel, N. (1980) Raised cytomegalovirus-antibody level in cerebrospinal fluid of schizophrenic patients. Lancet 2, 769-772.
169. Delisi, L. E., Smith, S. B., Hamovit, J. R., Maxwell, M. E., Goldin, L. R., Dingman, C. W., Gershon, E. S. (1986) Herpes simplex virus, cytomegalovirus and Epstein-Barr virus antibody titres in sera from schizophrenic patients. Psychol. Med. 16, 757-763.
170. Yamaguchi, K., Sawada, T., Naraki, T., Igata-Yi, R., Shiraki, H., Horii, Y., Ishii, T., Ikeda, K., Asou, N., Okabe, H., et al. (1999) Detection of Borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassay. Clin. Diagn. Lab. Immunol. 6, 696-700.
171. Leykin, I., Mayer, R., Shinitzky, M. (1997) Short and long-term immunosuppressive effects of clozapine and haloperidol. Immunopharmacology 37, 75-86.
172. Jankovic, J. (2001) Tourette's syndrome. N. Engl. J. Med. 345, 1184-1192.
173. Coffey, B. J., Park, K. S. (1997) Behavioral and emotional aspects of Tourette syndrome. Neurol. Clin. 15, 277-289.
174. Muller, N., Putz, A., Kathmann, N., Lehle, R., Gunther, W., Straube, A. (1997) Characteristics of obsessive-compulsive symptoms in Tourette's syndrome, obsessive-compulsive disorder, and Parkinson's disease. Psychiatry Res. 70, 105-114.
175. Hoekstra, P. J., Bijzet, J., Limburg, P. C., Steenhuis, M. P., Troost, P. W., Oosterhoff, M. D., Korf, J., Kallenberg, C. G., Minderaa, R. B. (2001) Elevated D8/17 expression on B lymphocytes, a marker of rheumatic fever, measured with flow cytometry in tic disorder patients. Am. J. Psychiatry 158, 605-610.
176. Hollander, E., DelGiudice-Asch, G., Simon, L., Schmeidler, J., Cartwright, C., DeCaria, C. M., Kwon, J., Cunningham-Rundles, C., Chapman, F., Zabriskie, J. B. (1999) B lymphocyte antigen D8/17 and repetitive behaviors in autism. Am. J. Psychiatry 156, 317-320.
177. Rickards, H., Dursun, S. M., Farrar, G., Betts, T., Corbett, J. A., Handley, S. L. (1996) Increased plasma kynurenine and its relationship to neopterin and tryptophan in Tourette's syndrome. Psychol. Med. 26, 857-862.
178. Leckman, J. F., Katsovich, L., Kawikova, I., Lin, H., Zhang, H., Kronig, H., Morshed, S., Parveen, S., Grantz, H., Lombroso, P. J., King, R. A. (2005) Increased serum levels of interleukin-12 and tumor necrosis factor-α in Tourette's syndrome. Biol. Psychiatry 57, 667-673.
179. Yeh, C. B., Wu, C. H., Tsung, H. C., Chen, C. W., Shyu, J. F., Leckman, J. F. (2006) Antineural antibody in patients with Tourette's syndrome and their family members. J. Biomed. Sci. 13, 101-112.
180. Hoekstra, P. J., Kallenberg, C. G., Korf, J., Minderaa, R. B. (2002) Is Tourette's syndrome an autoimmune disease? Mol. Psychiatry 7, 437-445.
181. Marques-Dias, M. J., Mercadante, M. T., Tucker, D., Lombroso, P. (1997) Sydenham's chorea. Psychiatr. Clin. North Am. 20, 809-820.
182. Kirvan, C. A., Swedo, S. E., Heuser, J. S., Cunningham, M. W. (2003) Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 9, 914-920.
183. Snider, L. A., Swedo, S. E. (2004) PANDAS: current status and directions for research. Mol. Psychiatry 9, 900-907.
184. Asbahr, F. R., Negrao, A. B., Gentil, V., Zanetta, D. M., da Paz, J. A., Marques-Dias, M. J., Kiss, M. H. (1998) Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am. J. Psychiatry 155, 1122-1124.
185. Lougee, L., Perlmutter, S. J., Nicolson, R., Garvey, M. A., Swedo, S. E. (2000) Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). J. Am. Acad. Child Adolesc. Psychiatry 39, 1120-1126.
186. Perlmutter, S. J., Leitman, S. F., Garvey, M. A., Hamburger, S., Feldman, E., Leonard, H. L., Swedo, S. E. (1999) Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354, 1153-1158.
187. Singer, H. S., Loiselle, C. R., Lee, O., Minzer, K., Swedo, S., Grus, F. H. (2004) Anti-basal ganglia antibodies in PANDAS. Mov. Disord. 19, 406-415.
188. Garvey, M. A., Perlmutter, S. J., Allen, A. J., Hamburger, S., Lougee, L., Leonard, H. L., Witowski, M. E., Dubbert, B., Swedo, S. E. (1999) A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol. Psychiatry 45, 1564-1571.
189. Kurlan, R. (2004) The PANDAS hypothesis: losing its bite? Mov. Disord. 19, 371-374.
190. McLean, B. N. (1998) Neurological involvement in systemic lupus erythematosus. Curr. Opin. Neurol. 11, 247-251.
191. Kowal, C., DeGiorgio, L. A., Nakaoka, T., Hetherington, H., Huerta, P. T., Diamond, B., Volpe, B. T. (2004) Cognition and immunity; antibody impairs memory. Immunity 21, 179-188.
192. Hoffman, S. A., Narendran, A., Shucard, D. W., Harbeck, R. J. (1988) Autoantibodies, immune complexes and behavioral disorders: neuropsychiatric involvement in systemic lupus erythematosus. Drug Dev. Res. 15, 237-251.
193. D'Andrea, M. (2004) Add Alzheimer's disease to the list of autoimmune diseases. Med. Hypotheses 64, 458-463.
194. Hofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., Grobbee, D. E. (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 349, 151-154.
195. Mecocci, P., Parnetti, L., Reboldi, G. P., Santucci, C., Gaiti, A., Ferri, C., Gernini, I., Romagnoli, M., Cadini, D., Senin, U. (1991) Blood-brainbarrier in a geriatric population: barrier function in degenerative and vascular dementias. Acta Neurol. Scand. 84, 210-213.
196. Kalaria, R. N. (1996) Cerebral vessels in ageing and Alzheimer's disease. Pharmacol. Ther. 72, 193-214.
197. Premkumar, D. R., Kalaria, R. N. (1996) Altered expression of amyloid β precursor mRNAs in cerebral vessels, meninges, and choroid plexus in Alzheimer's disease. Ann. N. Y. Acad. Sci. 777, 288-292.
198. Giulian, D. (1999) Microglia and the immune pathology of Alzheimer disease. Am. J. Hum. Genet. 65, 13-18.
199. Mark, K. S., Miller, D. W. (1999) Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-α exposure. Life Sci. 64, 1941-1953.